| Dr Daniel Jerald Minkin, MD | |
|
23 Crossroads Dr, 220, Owings Mills, MD 21117-5420 | |
| (410) 581-9200 | |
| (410) 581-9203 |
| Full Name | Dr Daniel Jerald Minkin |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 23 Crossroads Dr, Owings Mills, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740281757 | NPI | - | NPPES |
| 811500100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0043938 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Hospital Center | Randallstown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Researchers have found clear, identifiable factors that signal whether an athlete will experience concussive symptoms beyond one week. The researchers sought to identify risk factors for prolonged concussion symptoms by examining a large national database of high school athletes' injuries. Previous concussion studies were limited in scope, focusing only on male football players.
New research is challenging the notion that parents who divorce necessarily exhibit a diminished capacity to parent in the period following divorce.
RXi Pharmaceuticals Corporation, today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance imaging is the prevalence of motion artifacts-blurring and ghostly visual anomalies caused by patient motion on the table during imaging.
› Verified 4 days ago
| Entity Name | Sinai Hospital Of Baltimore, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043235666 PECOS PAC ID: 0941112346 Enrollment ID: O20031104000353 |
News Archive
Researchers have found clear, identifiable factors that signal whether an athlete will experience concussive symptoms beyond one week. The researchers sought to identify risk factors for prolonged concussion symptoms by examining a large national database of high school athletes' injuries. Previous concussion studies were limited in scope, focusing only on male football players.
New research is challenging the notion that parents who divorce necessarily exhibit a diminished capacity to parent in the period following divorce.
RXi Pharmaceuticals Corporation, today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance imaging is the prevalence of motion artifacts-blurring and ghostly visual anomalies caused by patient motion on the table during imaging.
› Verified 4 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140522000040 |
News Archive
Researchers have found clear, identifiable factors that signal whether an athlete will experience concussive symptoms beyond one week. The researchers sought to identify risk factors for prolonged concussion symptoms by examining a large national database of high school athletes' injuries. Previous concussion studies were limited in scope, focusing only on male football players.
New research is challenging the notion that parents who divorce necessarily exhibit a diminished capacity to parent in the period following divorce.
RXi Pharmaceuticals Corporation, today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance imaging is the prevalence of motion artifacts-blurring and ghostly visual anomalies caused by patient motion on the table during imaging.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Jerald Minkin, MD 23 Crossroads Dr, 220, Owings Mills, MD 21117-5420 Ph: (410) 581-9200 | Dr Daniel Jerald Minkin, MD 23 Crossroads Dr, 220, Owings Mills, MD 21117-5420 Ph: (410) 581-9200 |
News Archive
Researchers have found clear, identifiable factors that signal whether an athlete will experience concussive symptoms beyond one week. The researchers sought to identify risk factors for prolonged concussion symptoms by examining a large national database of high school athletes' injuries. Previous concussion studies were limited in scope, focusing only on male football players.
New research is challenging the notion that parents who divorce necessarily exhibit a diminished capacity to parent in the period following divorce.
RXi Pharmaceuticals Corporation, today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
Isis Pharmaceuticals, Inc. announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes.
One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance imaging is the prevalence of motion artifacts-blurring and ghostly visual anomalies caused by patient motion on the table during imaging.
› Verified 4 days ago
Dr. Margery Kates, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 23 Crossroads Dr, Suite 220, Owings Mills, MD 21117 Phone: 410-581-9200 Fax: 410-581-9203 | |
Dr. Sally Elizabeth Sondergaard, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 23 Crossroads Dr, Suite 220, Owings Mills, MD 21117 Phone: 410-581-9200 Fax: 410-581-9203 | |
Dr. Aimee C. Jacobs, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 23 Crossroads Dr, Suite 220, Owings Mills, MD 21117 Phone: 410-581-9200 | |
Dr. Murray Dennis Pearlman, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 23 Crossroads Dr, 220, Owings Mills, MD 21117 Phone: 410-581-9200 Fax: 410-581-9203 | |
Mariana Ximena Martinez Telleria, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 23 Crossroads Drive, Suite 220, Owings Mills, MD 21117 Phone: 410-581-9200 Fax: 410-551-0842 | |
Eli Anthony Timoll, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2217 Shaded Brook Drive, Owings Mills, MD 21117 Phone: 410-363-4341 Fax: 410-363-6569 | |
Dr. Jennie Faber, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 23 Crossroads Dr, Suite 220, Owings Mills, MD 21117 Phone: 410-581-9200 Fax: 410-581-9203 |